Organon & Co.: Eczema trials

The registry lists 13 Eczema studies with Organon & Co. as lead sponsor. 0 are open to participants now and 6 have results posted.

Phase 1 3Phase 2 6Phase 3 5Phase 4 1(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Maximal Use Study of Tapinarof Cream, 1% in Pediatric Subjects With Extensive Atopic DermatitisCompletedNCT05186805Phase 2Results posted
• Long Term Extension Study of Tapinarof Cream, 1% for Subjects With Atopic DermatitisCompletedNCT05142774Phase 3Results posted
• Tapinarof for the Treatment of Atopic Dermatitis in Children and Adults (DMVT-505-3102)CompletedNCT05032859Phase 3Results posted
• Tapinarof for the Treatment of Atopic Dermatitis in Children and AdultsCompletedNCT05014568Phase 3Results posted
• Efficacy and Safety Study of Desloratadine (MK-4117) in Japanese Participants With Eczema/Dermatitis and Dermal Pruritus (MK-4117-202)CompletedNCT01916980Phase 3Results posted
• Safety and Efficacy of Quadriderme® in the Treatment of Impetiginous Eczema (Study P05134AM4)TerminatedNCT00671528Phase 4Results posted
• A Study to Investigate Safety and Efficacy of Tapinarof Cream, 1% in Participants Ages 3 Months to < 24 Months With Atopic DermatitisSuspendedNCT07265479Phase 3
• Open-Label Study of RVT-501 Topical Ointment in Pediatric Patients With Atopic DermatitisStatus unknownNCT03415282Phase 1
• Study of RVT-501 Topical Ointment in Pediatric Patients With Atopic DermatitisCompletedNCT03394677Phase 2
• Study of RVT-501 in Adult and Adolescent Subjects With Atopic DermatitisCompletedNCT02950922Phase 2
• A Phase 1/2 Study of E6005 in Pediatric Subjects With Atopic DermatitisCompletedNCT02094235Phase 1/2
• A Phase 2 Study of E6005 in Patients With Atopic DermatitisCompletedNCT01461941Phase 2
• A Study of E6005 in Japanese Patients With Atopic DermatitisCompletedNCT01179880Phase 1/2